[1] 武少华,范志宏,罗静,等.新诊断2型糖尿病患者血清鸢尾素与网膜素-1水平变化的相关研究[J].中国药物与临床,2019,19(1):32-34.
[2] 徐海波,闫晓光,钟威.新诊断2型糖尿病患者血清Nesfatin-1、肿瘤坏死因子-α水平与胰岛素抵抗的相关性研究[J].中国糖尿病杂志,2017,25(1):45-48.
[3] 张旭艳,丁胜,杨帆,等.血清P选择素、胰高血糖素样肽-1与初诊断2型糖尿病患者胰岛素抵抗的关系[J].中华保健医学杂志,2019,21(3):198-201.
[4] 刘书苑,张岩,马红,等.新诊断2型糖尿病患者血清Pannexin-1,Apelin,RBP4,VEGF水平与糖脂代谢和胰岛素抵抗的关系研究[J].现代生物医学进展,2020,20(23):4492-4496.
[5] Tozzi M,Hansen JB,Novak I,et al.Pannexin-1 mediated ATP release in adipocytes is sensitive to glucose and insulin and modulates lipolysis and macrophage migration[J].Acta Physiol(Oxf),2020,228(2):e13360.
[6] 刘彩红,张彦伟,刘雯霞,等.血清CTRP1和CTRP7水平与冠心病合并糖尿病的关系[J].中国病理生理杂志,2020,36(8):1470-1475.
[7] 李园园. 血清pannexin-1,CTRP1水平变化与新诊断2型糖尿病患者HOMA-IR的关联性探究[J].医学检验与临床,2021,32(10):59-61. |
2023, Vol. 43 
